文献速递中毒与环境急症消化、代谢与肾脏急症

铁过量流行病学、临床特征及铁浓度-效应关系:2008-2017年英国经验

Iron overdose epidemiology, clinical features and iron concentration-effect relationships: the UK experience 2008-2017.
PubMed 文献 · Clin Toxicol (Phila) · 2018-03-28
一句话结论英国医院转诊的铁过量病例以5岁以下儿童和13-20岁年轻女性为主,本队列为轻中度中毒,无死亡,报告剂量与早期铁浓度无相关性,铁浓度与症状无相关性。

该研究基于英国国家毒物信息服务(NPIS)数据库,分析2008年1月1日至2017年7月31日医院转诊的铁过量病例。共2708例铁过量患者,其中1839例为单剂铁摄入。单剂暴露年龄分布呈双峰:539/1839(28.4%)为<6岁(男性54.1%),675/1839(36.7%)为13-20岁(女性91%),后者比例显著高于同期NPIS全部医院转诊中13-20岁比例(23776/144268,16.5%;女性67.5%)(p<.0001)。在475例青少年和成人及86例儿童中,报告剂量与摄入后4-6小时铁浓度无相关性;成人观察到的峰值铁浓度与报告症状无关。30例(25例成人,5例儿童)接受去铁胺(DFO)治疗者初始铁浓度显著高于未接受DFO者[未用DFO:均值63.8 μmol/L(95%CI 62.1-65.6),中位数64;DFO:均值78.5 μmol/L(95%CI 69.2-87.7),中位数78.1;Mann-Whitney p<.0018],但治疗前症状两组无显著差异。本队列无死亡,未发现器官衰竭中毒。

要点

  • 单剂铁暴露年龄分布呈双峰:<6岁占28.4%(539/1839,男性54.1%),13-20岁占36.7%(675/1839,女性91%),后者显著高于同期全部NPIS医院转诊该年龄段比例(16.5%,p<.0001)。
  • 在475例青少年和成人及86例儿童中,报告的铁剂量与摄入后4-6小时测得的铁浓度无相关性。
  • 成人观察到的峰值铁浓度与报告症状无关。
  • 接受去铁胺(DFO)治疗的30例(25例成人,5例儿童)初始铁浓度显著高于未接受DFO者[未用DFO均值63.8 μmol/L(95%CI 62.1-65.6),DFO均值78.5 μmol/L(95%CI 69.2-87.7),p<.0018],但治疗前症状两组无显著差异。
  • 本队列无死亡,未发现器官衰竭中毒,提示为轻中度中毒人群。

适用人群与场景

  • 英国医院转诊至国家毒物信息服务(NPIS)的铁过量患者,单剂铁摄入者纳入分析。
  • 年龄分布包括<6岁儿童(539/1839,28.4%)和13-20岁青少年及年轻成人(675/1839,36.7%)。
  • 铁浓度-效应分析纳入至少有一次定时铁浓度的475例青少年和成人(≥13岁)及86例儿童(≤12岁)。

研究设计与关键结果

  • 研究类型:基于NPIS数据库的回顾性队列分析,研究期间为2008年1月1日至2017年7月31日(9.7年)。
  • 样本量:共2708例铁过量医院转诊患者,其中1839例为单剂铁摄入。
  • 年龄分布:单剂暴露中<6岁539/1839(28.4%,男性54.1%),13-20岁675/1839(36.7%,女性91%);13-20岁比例显著高于同期全部NPIS医院转诊该年龄段比例(23776/144268,16.5%;女性67.5%)(p<.0001)。
  • 剂量-浓度关系:在475例青少年和成人和86例儿童中,报告剂量与摄入后4-6小时铁浓度无相关性。
  • 浓度-症状关系:成人观察到的峰值铁浓度与报告症状无关。
  • 去铁胺治疗:30例(25例成人,5例儿童)接受DFO;初始铁浓度DFO组均值78.5 μmol/L(95%CI 69.2-87.7),中位数78.1;未用DFO组均值63.8 μmol/L(95%CI 62.1-65.6),中位数64;Mann-Whitney p<.0018;治疗前症状两组无显著差异。
  • 结局:本队列无死亡,未发现器官衰竭中毒。

证据类型、等级与局限

  • 证据类型:基于英国国家毒物信息服务(NPIS)数据库的回顾性队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 本队列为轻中度铁过量中毒,报告的铁剂量与早期铁浓度无相关性,铁浓度与症状无相关性,提示不能仅凭报告剂量或早期铁浓度预测症状严重程度。
  • 接受去铁胺治疗的患者初始铁浓度更高,但治疗前症状无显著差异,作者未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Iron poisoning is potentially serious, but mortality has fallen worldwide since implementation of pack size and packaging restrictions, and changes in iron use during pregnancy. The management of individual cases of overdose remains problematic due to uncertainty about indications for antidote. We examine the epidemiology of iron overdose in hospital cases referred to the UK National Poisons Information Service (NPIS) and evaluate the toxicokinetics of iron in patients ingesting only iron preparations. Methods: Anonymized hospital referral patient data from the NPIS database were collated for the period 1 January 2008 to 31 July 2017. Information was extracted, where recorded, on type of ingestion [iron alone (single), or combined with other agents (mixed)], reported dose, iron salt, timed iron concentrations and symptoms. In single-agent ingestions, the relationships between reported elemental iron dose, early concentrations (4-6 h), and symptoms were evaluated in teenagers and adults (≥13 years) and children (≤12 years) using standard statistical techniques (correlation and unpaired nonparametric comparisons). In those patients with sufficient sample points (three or more), a simple kinetic analysis was conducted. Results: Of 2708 patients with iron overdoses referred by UK hospitals for advice during the 9.7 years study period, 1839 were single-agent ingestions. There were two peaks in age incidence in single-agent exposures; 539/1839 (28.4%) were <6 years (54.1% males) while 675/1839 (36.7%) were between 13 and 20 years (91% females), the latter a substantial excess over the proportion in the totality of hospital referrals to the NPIS in the same period (13-20 years: 23,776/144,268 16.5%; 67.5% female) (p < .0001 overall and for female %). In 475 teenagers and adults and 86 children, with at least one-timed iron concentration available, there was no correlation between stated dose and iron concentration measured 4-6 h post-ingestion. Observed peak iron concentrations were not related to reported symptoms in adults. Initial iron concentrations were significantly higher in 30 patients (25 adults, 5 children) who received desferrioxamine (DFO) compared to those that did not [no DFO: mean 63.8 μmol/L (95% CI 62.1-65.6), median 64; DFO: mean 78.5 μmol/L (95% CI 69.2-87.7), median 78.1; Mann-Whitney p < .0018). No significant differences in symptoms were observed pre-treatment between DFO-treated and untreated groups. No patients died in this cohort. Conclusion: Single-agent iron exposures reported from UK hospitals were most common in children <5 years and young people aged 13-20 years. Poisoning with organ failure was not identified and there were no fatalities. No correlations were observed between reported iron doses and early concentrations, or between iron concentrations and symptoms in this cohort of mild-to-moderate poisoning.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Bateman DN, Eagling V, Sandilands EA, et al. Iron overdose epidemiology, clinical features and iron concentration-effect relationships: the UK experience 2008-2017. Clin Toxicol (Phila). 2018. PMID: 29587543. doi:10.1080/15563650.2018.1455978

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。